Is Fatty15 “Fool’s Gold?”
Dry Mouth? Clinically Proven Relief is Here!
The Importance of Oral Health Care
ThymoQuin®: The Premier Black Seed Oil
The Truth About Alcohol and Health
The latest prescription weight loss craze is a once-weekly injection of Wegovy (semaglutide) at a cost of over $1,400 per month. Wegovy is a higher dosage version of Ozempic, a drug also produced by big pharma giant Novo Nordisk A/S that was approved for the treatment of type 2 diabetes in 2017. Wegovy was approved for weight loss by the United States FDA in 2021.
Semaglutide works as a GLP-1 receptor agonist, which means that it acts like a compound that we make in our body known as human glucagon-like peptide-1 (GLP-1). Semaglutide is chemically 94% identical to human GLP-1. But it behaves much differently (discussed below) and that creates potential problems.
Dr. Murray’s Top 7 Superfoods
Building a Supplement Program: The Importance of a Foundation
Welcome
October is National Breast Cancer Awareness Month
Breast cancer has reached near epidemic status among American women as it is currently estimated that one out of eight women in the United States will develop breast cancer in her lifetime. Currently, breast cancer causes over 40,000 deaths in the United States each year.
The rate of breast cancer is typically 5 times higher for women in the United States compared to women in many other parts of the world. It is interesting to note that in Japan the rate of breast cancer is about 1/5th the rate in the United States, but in second or third generation Japanese women living in America eating the typical American diet the rate of breast cancer is identical to other women living in the United States.
Read the rest of the article here
For more information on steps you can take to reduce the risk of breast cancer, please refer to the corresponding chapter in the 3rd Edition of The Encyclopedia of Natural Medicine.
For more information, please see the completely revised and updated 3rd edition of The Encyclopedia of Natural Medicine.